UnitedHealth Group (NYSE:UNH) says at least 84% of its Q2 beat is now in its outlook; Elevance Health (NYSE:ELV) moved 20%
NEW YORK, July 16, 2026, 06:23 EDT UnitedHealth bumped up the lower end of its 2026 adjusted EPS outlook by $1.25 after topping second-quarter estimates by $1.48. Elevance also raised its floor…
Read the full articleYou might also wanna read
UnitedHealth Group (NYSE:UNH) Surges on Massive Earnings Beat, Raising Full-Year Guidance
UnitedHealth Group Q2 2026 earnings beat estimates with $6.38 EPS, surging 6.8% pre-market. Revenue hit $112B, guided FY2026 EPS to $19.50-$
UnitedHealth (UNH) Q2 Earnings Preview: Wall Street Predictions for July 16 Report
UnitedHealth (UNH) reports Q2 earnings July 16. Analysts project $4.85 EPS, $110.76B revenue. Options market prices 6.27% post-earnings move
UnitedHealth Surged 10% Intraday After Earnings. Here’s Where UNH Stock Could Head in 2026
UnitedHealth stock surged as much as 10% intraday after earnings beat expectations and management raised its 2026 outlook. Here’s why improv
UnitedHealth Stock Update: Q2 Earnings Beat and AI Strategy Explained
UnitedHealth beat Q2 2026 earnings estimates, raised full-year guidance and highlighted its $3 billion AI strategy as improved cost controls
The Main Reason Behind Buying UnitedHealth Before July 16
UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, an
UnitedHealth (UNH) Stock Slides Before Thursday’s Q2 Earnings Report
UnitedHealth (UNH) stock drops ahead of Thursday's Q2 earnings. Analysts expect $4.85 EPS, $110.77B revenue. Buy rating with $432.63 target
Comments
Sign in to join the conversation.
No comments yet. Be the first.